Ferrer is a family-owned pharmaceutical company based in Barcelona. Our business is not an end in itself, but a means to generate substantial social change. We work to achieve a minimum level of profitability that guarantees the company's sustainability and to reinvest a large part of our profits in initiatives with social and environmental impact, as well as in our people.

This purpose is central to each and every one of the decisions that we make in our day-to-day work. Our conviction is such that the company's strategic plan consists of just three pillars that define and will continue to define what we want to achieve in the future: great people, liveable planet and social justice.

To support Ferrer's purpose of using our business to fight for social justice, the R&D team aims to develop and deliver transformative therapeutic solutions for people living with severe and debilitating diseases.

Innovation is an inherent part of our pharmaceutical development, and we have always upheld our commitment in searching for and developing new treatment alternatives aimed at addressing unmet medical needs in order to improve the patients' quality of life and creating value for physicians, health systems and society in two main areas: pulmonary-vascular interstitial lung diseases and neurological disorders.